Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION trial

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2632-2636

  Brugaletta, Salvatore ^a   Sabate, Manel ^a   Martin Yuste, Victoria ^d   Masotti, Monica ^a   Shiratori, Yoshitaka ^a   Alvarez Contreras, Luis ^a   Cequier, Angel ^b   Iñiguez, Andrés ^c   Serra, Antonio ^d   Hernandez Antolin, Rosana ^e   Mainar, Vicente ^f   Valgimigli, Marco ^g   Tespili, Maurizio ^h   Den Heijer, Pieter ⁱ   Bethencourt, Armando ^j   Vazquez, Nicolás ^k   Gomez Lara, Josep ^b   Backx, Bianca ^l   Serruys, Patrick W ^m  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL DO MEIXOEIRO   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^f Hospital General of Alicante   (Spain)

^g UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^h University Hospital Bolognini Seriate   (Italy)

ⁱ AMPHIA HOSPITAL   (Netherlands)

^j HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^k HOSPITAL JUAN CANALEJO   (Spain)

^l CARDIALYSIS   (Netherlands)

^m ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

Everolimus eluting stent; STEMI; Stent thrombosis

Indexed keywords

EVEROLIMUS;

ADULT; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; DRUG ELUTING STENT; EVEROLIMUS ELUTING STENT; FEMALE; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TARGET VESSEL REVASCULARIZATION; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THROMBOSIS;

DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; THROMBOSIS;

EID: 84885604096     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.03.036     Document Type: Article

References (39)

1. W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
2. C. Spaulding, P. Henry, and E. Teiger Sirolimus-eluting versus uncoated stents in acute myocardial infarction N Engl J Med 355 2006 1093 1104
3. C. Spaulding, E. Teiger, and P. Commeau Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty) JACC Cardiovasc Interv 4 2011 14 23
4. A. Kastrati, J. Mehilli, and J. Pache Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039
5. J. Daemen, P. Wenaweser, and K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
6. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
7. G. Sianos, M.I. Papafaklis, and J. Daemen Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden J Am Coll Cardiol 50 2007 573 583
8. G. Nakazawa, A.V. Finn, and M. Vorpahl Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis J Am Coll Cardiol 54 2009 1924 1931
9. N. Gonzalo, P. Barlis, and P.W. Serruys Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography JACC Cardiovasc Interv 2 2009 445 452
10. M. Pfisterer, H.P. Brunner-La Rocca, and P.T. Buser Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2006 2584 2591
11. G.W. Stone, J.W. Moses, and S.G. Ellis Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
12. L.O. Jensen, P. Thayssen, and H.S. Hansen Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV) Circulation 125 2012 1246 1255
13. E. Kedhi, K.S. Joesoef, and E. McFadden Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial Lancet 375 2010 201 209
14. G.W. Stone, M. Midei, and W. Newman Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial JAMA 299 2008 1903 1913
15. G.W. Stone, A. Rizvi, and W. Newman Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
16. P.W. Serruys, S. Silber, and S. Garg Comparison of zotarolimus-eluting and everolimus-eluting coronary stents N Engl J Med 363 2010 136 146
17. M. Sabate, A. Cequier, and A. Iniguez Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial Lancet 380 2012 1482 1490
18. G.D. Dangas, A. Caixeta, and R. Mehran Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction Circulation 123 2011 1745 1756
19. M. Sabate, A. Cequier, and A. Iniguez Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction EuroIntervention 7 2011 977 984
20. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
21. H. Akaike A new look at the statistical model identification IEEE Trans Autom Control 19 1974 716 723
22. A.V. Finn, G. Nakazawa, and M. Joner Vascular responses to drug eluting stents: importance of delayed healing Arterioscler Thromb Vasc Biol 27 2007 1500 1510
23. B. Lagerqvist, J. Carlsson, and O. Frobert Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry Circ Cardiovasc Interv 2 2009 401 408
24. G.J. Laarman, M.J. Suttorp, and M.T. Dirksen Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention N Engl J Med 355 2006 1105 1113
25. M. Valgimigli, G. Campo, and G. Percoco Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial JAMA 299 2008 1788 1799
26. G.W. Stone, B. Witzenbichler, and G. Guagliumi Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
27. M.C. John, R. Wessely, and A. Kastrati Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents JACC Cardiovasc Interv 1 2008 535 544
28. J.W. van Werkum, A.A. Heestermans, and F.I. de Korte Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases Circulation 119 2009 828 834
29. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
30. S.S. Brar, M.B. Leon, and G.W. Stone Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis J Am Coll Cardiol 53 2009 1677 1689
31. J.J. Smit, A.W. van 't Hof, and M.J. de Boer Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarction Thromb Haemost 96 2006 190 195
32. R. Beinart, R. Abu Sham'a, and A. Segev The incidence and clinical predictors of early stent thrombosis in patients with acute coronary syndrome Am Heart J 159 2010 118 124
33. L. Raber, M. Magro, and G.G. Stefanini Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study Circulation 125 2012 1110 1121
34. T. Palmerini, G. Biondi-Zoccai, and D. Della Riva Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
35. D. Planer, P.C. Smits, and D.J. Kereiakes Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) Trials JACC Cardiovasc Interv 4 2011 1104 1115
36. S. Bangalore, S. Kumar, and M. Fusaro Short and long-term outcomes with drug eluting and bare metal coronary stents: a mixed treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials Circulation 125 2012 2873 2891
37. K. Kolandaivelu, R. Swaminathan, and W.J. Gibson Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings Circulation 123 2011 1400 1409
38. G. Guagliumi, M.A. Costa, and V. Sirbu Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial Circulation 123 2011 274 281
39. H.H. Choi, J.S. Kim, and D.H. Yoon Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography Int J Cardiovasc Imaging 28 2012 491 497